Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion

Macular edema (ME) is the most frequent vision threatening consequence after retinal vein occlusion (RVO). In this study, we evaluate the effect of dexamethasone intravitreal implants (DII, Ozurdex) in a real-life cohort of 99 patients with ME due to RVO. All patients who received DII for ME followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wecker, Thomas, Grundel, Bastian, Grundel, Milena, Bründer, Marie-Christine, Trick, Simon, Lange, Clemens, Böhringer, Daniel, Agostini, Hansjürgen, Stahl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050279/
https://www.ncbi.nlm.nih.gov/pubmed/33859243
http://dx.doi.org/10.1038/s41598-021-87467-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050279/
https://www.ncbi.nlm.nih.gov/pubmed/33859243
http://dx.doi.org/10.1038/s41598-021-87467-6

Ejemplares similares